<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>CAD-RADS reporting and data system for patients presenting with stable chest pain</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">CAD-RADS reporting and data system for patients presenting with stable chest pain</h1>
<div class="graphic"><div class="figure"><div class="ttl">CAD-RADS reporting and data system for patients presenting with stable chest pain</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="17.5%"></colgroup><colgroup width="30%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Degree of maximal coronary stenosis</td> <td class="subtitle1">Interpretation</td> <td class="subtitle1">Further cardiac investigation</td> <td class="subtitle1">Management</td> </tr> <tr class="divider_bottom"> <td><strong>CAD-RADS 0</strong></td> <td>0% (no plaque or stenosis)</td> <td>Documented absence of CAD</td> <td>None</td> <td> <ul> <li>Reassurance. Consider non-atherosclerotic causes of chest pain. </li> </ul> </td> </tr> <tr class="divider_bottom"> <td><strong>CAD-RADS 1</strong></td> <td>1 to 24% (minimal stenosis or plaque with no stenosis*)</td> <td>Minimal non-obstructive CAD</td> <td>None</td> <td> <ul> <li>Consider non-atherosclerotic causes of chest pain. </li> <li>Consider preventive therapy and risk factor modification. </li> </ul> </td> </tr> <tr class="divider_bottom"> <td><strong>CAD-RADS 2</strong></td> <td>25 to 49% (mild stenosis)</td> <td>Mild non-obstructive CAD</td> <td>None</td> <td> <ul> <li>Consider non-atherosclerotic causes of chest pain. </li> <li>Consider preventive therapy and risk factor modification, particularly for patients with non-obstructive plaque in multiple segments. </li> </ul> </td> </tr> <tr class="divider_bottom"> <td><strong>CAD-RADS 3</strong></td> <td>50 to 69% (moderate stenosis)</td> <td>Moderate stenosis</td> <td>Consider functional assessment</td> <td> <ul> <li>Consider symptom-guided anti-ischemic and preventive pharmacotherapy as well as risk factor modification per guideline-directed care.<sup>¶</sup> </li> <li>Other treatments should be considered per guideline-directed care.<sup>¶</sup> </li> </ul> </td> </tr> <tr class="divider_bottom"> <td><strong>CAD-RADS 4</strong></td> <td> <p><strong>A:</strong> 70 to 99% (severe stenosis)</p> <p>or</p> <strong>B:</strong> &gt;50% (left main) or ≥70% (3-vessel) obstructive disease </td> <td>Severe stenosis</td> <td> <p><strong>A:</strong> Consider ICA or functional assessment</p> <strong>B:</strong> ICA is recommended </td> <td> <ul> <li>Consider symptom-guided anti-ischemic and preventive pharmacotherapy as well as risk factor modification per guideline-directed care.<sup>¶</sup> </li> <li>Other treatments (including options of revascularization) should be considered per guideline-directed care.<sup>¶</sup> </li> </ul> </td> </tr> <tr class="divider_bottom"> <td><strong>CAD-RADS 5</strong></td> <td>100% (total occlusion)</td> <td>Total coronary occlusion</td> <td>Consider ICA and/or viability assessment</td> <td> <ul> <li>Consider symptom-guided anti-ischemic and preventive pharmacotherapy as well as risk factors modification per guideline-directed care.<sup>¶</sup> </li> <li>Other treatments (including options of revascularization) should be considered per guideline-directed care.<sup>¶</sup> </li> </ul> </td> </tr> <tr> <td><strong>CAD-RADS N</strong></td> <td>Non-diagnostic study</td> <td>Obstructive CAD cannot be excluded</td> <td>Additional or alternative evaluation may be needed</td> <td> </td> </tr> </tbody></table></div><div class="graphic_lgnd">The CAD-RADS classification should be applied on a per-patient basis for the clinically most relevant (usually highest-grade) stenosis. All vessels greater than 1.5 mm in diameter should be graded for stenosis severity. CAD-RADS will not apply for smaller vessels (&lt;1.5 mm in diameter).<br/><strong>MODIFIERS:</strong> If more than one modifier is present, the symbol "/" (slash) should follow each modifier in the following order: 

<ul class="decimal_heading">
<li>First: modifier N (non-diagnostic)</li>
<li>Second: modifier S (stent)</li>
<li>Third: modifier G (graft)</li>
<li>Fourth: modifier V (vulnerability)</li></ul></div><div class="graphic_footnotes">CAD-RADS: coronary artery disease-reporting and data system; CAD: coronary artery disease; ICA: invasive coronary angiography; ACC: American College of Cardiology.<br/>* CAD-RADS 1 — This category should also include the presence of plaque with positive remodeling and no evidence of stenosis.<br/>¶ <span style="COLOR: black">Refer to UpToDate content on secondary prevention of atherosclerotic cardiovascular disease.</span></div><div class="graphic_reference">Reproduced from: Cury RC, Abbara S, Achenbach S, et al. CAD-RADSTM Coronary Artery Disease — Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comut Tomogr 2016; 10:269. Table used with the permission of Elsevier Inc. All rights reserved.</div><div id="graphicVersion">Graphic 120199 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
